HCPCS Level IIdrugActive
J7210
Inj, afstyla, 1 i.u.
BETOS: O1E
Effective: 2018-01-01
Referenced in 5 policies
Description
Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Afstyla
Manufacturer
CSL Behring L.L.C.
HCPCS Dosage
1 IU
Billing Units
1.0000
7
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.